Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Federal Trade Commission
Cantor Fitzgerald
Daiichi Sankyo
Harvard Business School

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,464,864

« Back to Dashboard

Summary for Patent: 5,464,864

Title: Use of tetrahydrocarbazone derivatives as 5HT.sub.1 receptor agonists
Inventor(s): King; Francis D. (Harlow, GB2), Gaster; Laramie M. (Harlow, GB2), Kaumann; Alberto J. (Trumpington, GB2), Young; Rodney C. (Hertford, GB2)
Assignee: SmithKline Beecham P.L.C. (Brentford, GB2)
Application Number:08/167,846
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,464,864

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9113802Jun 26, 1991
PCT Information
PCT FiledJune 17, 1992PCT Application Number:PCT/GB92/01082
PCT Publication Date:January 07, 1993PCT Publication Number: WO93/00086

International Patent Family for Patent: 5,464,864

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Israel117104► Subscribe
Israel102322► Subscribe
Ireland922062► Subscribe
Czech Republic282327► Subscribe
Czech Republic9601506► Subscribe
Germany10299042► Subscribe
Germany69226953► Subscribe
Denmark0591280► Subscribe
European Patent Office0591280► SubscribeSPC/GB03/014United Kingdom► Subscribe
European Patent Office0591280► SubscribeC00591280/01Switzerland► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Johnson and Johnson
Federal Trade Commission
Daiichi Sankyo
Chinese Patent Office
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: